1. Home
  2. ARQT vs GOGL Comparison

ARQT vs GOGL Comparison

Compare ARQT & GOGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • GOGL
  • Stock Information
  • Founded
  • ARQT 2016
  • GOGL N/A
  • Country
  • ARQT United States
  • GOGL Bermuda
  • Employees
  • ARQT N/A
  • GOGL N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • GOGL Marine Transportation
  • Sector
  • ARQT Health Care
  • GOGL Consumer Discretionary
  • Exchange
  • ARQT Nasdaq
  • GOGL Nasdaq
  • Market Cap
  • ARQT 1.7B
  • GOGL 1.6B
  • IPO Year
  • ARQT 2020
  • GOGL 1997
  • Fundamental
  • Price
  • ARQT $14.29
  • GOGL $8.37
  • Analyst Decision
  • ARQT Strong Buy
  • GOGL Hold
  • Analyst Count
  • ARQT 7
  • GOGL 2
  • Target Price
  • ARQT $18.67
  • GOGL $10.25
  • AVG Volume (30 Days)
  • ARQT 1.5M
  • GOGL 3.4M
  • Earning Date
  • ARQT 08-06-2025
  • GOGL 08-27-2025
  • Dividend Yield
  • ARQT N/A
  • GOGL 12.54%
  • EPS Growth
  • ARQT N/A
  • GOGL N/A
  • EPS
  • ARQT N/A
  • GOGL 0.57
  • Revenue
  • ARQT $212,819,000.00
  • GOGL $863,612,000.00
  • Revenue This Year
  • ARQT $61.83
  • GOGL N/A
  • Revenue Next Year
  • ARQT $36.55
  • GOGL $11.09
  • P/E Ratio
  • ARQT N/A
  • GOGL $14.71
  • Revenue Growth
  • ARQT 100.03
  • GOGL N/A
  • 52 Week Low
  • ARQT $7.86
  • GOGL $6.27
  • 52 Week High
  • ARQT $17.75
  • GOGL $13.44
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 46.02
  • GOGL 55.35
  • Support Level
  • ARQT $14.44
  • GOGL $8.12
  • Resistance Level
  • ARQT $15.38
  • GOGL $8.72
  • Average True Range (ATR)
  • ARQT 0.66
  • GOGL 0.22
  • MACD
  • ARQT -0.09
  • GOGL -0.02
  • Stochastic Oscillator
  • ARQT 10.19
  • GOGL 47.76

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About GOGL Golden Ocean Group Limited

Golden Ocean Group Ltd is a Bermuda-based dry bulk shipping company. Its business involves the transportation of dry bulk cargo including ores, coal, grains and fertilizers through its fleet of owned and chartered vessels, bareboat vessels, commercial management vessels and new buildings are chartered-out on fixed rate time charters and index-linked time charter contracts. The Company's single operating segment derives revenue from transporting dry bulk cargoes and chartering vessels to customers on time charter or voyage charter contracts.

Share on Social Networks: